Advocacy and Professional Issues
The Dawn of the 21st Century/Pat DeLeon
Onward to the Future: Professional Psychology Evolves/Ron Levant
Telehealth: The Furthering of Psychology as a Profession/Marlene M. Maheu
APA Ethics Committee Considered Prohibiting Solo Practice/Martin Williams
Laws and Ethics as Double Binds: Selecting the Spectrum of Resolutions /Arthur M. Bodin
Taking Action on Consumer Choice/Arthur Kovacs
Rescue Health Day is Coming April 1, 2000/Karen Shore
Managed Care Aggression Syndrome - Etiology, Symptomatology and Resolution/Ernie R. Downs
Transitioning from Therapy to Coaching: An Interview with Dr. Diane Menendez/Patrick Williams
APA’s Examination in Psychopharmacology: Project Nearing Completion/Janet Ciuccio
Treating of Major Depression in Primary Care Practices: A Critique of Guidelines/Jack Wiggins

Janet Ciuccio APA’s Examination in Psychopharmacology: Project Nearing Completion

In August 1997 APA’s Council of Representatives authorized the College of Professional Psychology to develop an examination in psychopharmacology intended for use by state licensing boards in awarding prescriptive authority to psychologists. The project is nearing completion and the examination will be ready for use in early 2000. The last two years have involved extensive and systematic work on the part of the College’s Expert Working Group in Psychopharmacology and its exam contractor, Professional Examination Services (PES).

The products of this work are several. In addition to two forms of an examination comprised of 150 multiple-choice items each, the content areas and associated knowledge statements comprise a valid and defensible statement of the knowledge required for the safe and effective practice of psychology when psychotropic medications are involved. The ten content areas to be tested are presented below. The relative emphasis on the examination is represented parenthetically. A list of the 114 associated knowledge statements can be obtained by contacting the College (see end of article for contact information).

Ten Content Areas to be Tested

  1. Integrating clinical psychopharmacology with the practice of psychology (15%) - Refers to the implementation of clinical practices of biophychosocial assessment, multiaxial diagnosis, and treatment including pharmacotherapy, in the context of a complex of factors influencing functioning. These factors include biological (e.g., genetic, sex, age, disease), psychological (e.g., cognitive, emotional, dynamic, motivational, behavioral), psychosocial (e.g., gender, cultural/ethnic, interpersonal), and ecological/environmental factors.
  2. Neuroscience (8%)- Refers to the anatomy, physiology, and biochemistry of the nervous system and its interface with other major body systems.
  3. Nervous system pathology (9%) - Refers to disorders of the nervous system resulting in abnormal function or behavioral/mood disruption. Includes biochemical, structural (congenital or acquired), or neurophysiological abnormalities and their impact on other body systems.
  4. Physiology and pathophysiology (9%) - Refers to normal physiology and pathophysiology across the life span, and to their impact on psychological functioning and psychopharmacology.
  5. Biopsychosocial and pharmacologic assessment and monitoring (10%)- Refers to a range of biopsychosocial (psychological, neurological, behavioral, physical, biomedical) and pharmacologic assessment techniques and procedures for baseline and ongoing evaluation of the individual’s physical and psychological health status as well as the assessment of therapeutic efficacy, adverse effects, contraindications for usage, drug interactions, and appropriateness for medication continuation, modification, or discontinuation.
  6. Differential diagnosis (13%)- Refers to the use of comprehensive diagnostic information about a patient to establish an accurate diagnosis from possible medical and psychological diagnoses in order to select appropriate treatment modalities and determine appropriateness for referral to other health care providers.
  7. Pharmacology (12%) - Refers to the interactions of drugs with biophysiological systems; encompasses pharmacokinetics, pharmacodynamics, pharmacogenetics, and the epidemiology of various medications such as psychotropics, adjunctive agents, and other medications used in the practice of medicine, as well as substances of abuse, over the counter (OTC) products, food and dietary supplements. The influence of cultural/ethnic factors, environmental factors, and responses of special populations are considered.
  8. Clinical psychopharmacology (13%)- Refers to the application of pharmacology to the management of psychological/behavioral disorders. This includes indications, contraindications, dosing, adverse effects and toxicities of psychotropic and adjunctive medications, interactions with other medications (including other drugs used in medicine, for recreational purposes, and available for OTC purchase) as well as the management of adverse reactions, overdoses, and toxicities.
  9. Research (4%) - Refers to the methodology, standards, and conduct of research on psychoactive substances. The knowledge base facilitates research design and implementation, accurate data interpretation and communication, effective utilization of findings, the accumulation of scientific knowledge, and the improvement of the practice of clinical psychopharmacology.
  10. Professional, legal, ethical, and interprofessional issues (7%)- Refers to knowledge of ethics, standards of care, laws, and regulations relevant to the practice of psychology involving psychopharmacology.

Exam Development Methodology

All procedures used to develop the examination are consistent with the technical guidelines described in the Standards for Educational and Psychological Testing (AERA/APA/NCME, 1985), relevant sections of the Uniform Guidelines on Employee Selection Procedures (EEOC, Civil Service Commission, U.S. Department of Labor and U.S. Department of Justice, 1978) and the PES Guidelines for the Development, Use, and Evaluation of Licensure and Certification Programs (PES, 1995).

Briefly, these standards require that the exam be a valid measure of the important activities of a job and the associated knowledge needed to perform those activities in a safe and effective manner (content validity). To ensure compliance, the Board of Governors of the College contracted with PES to guide the development of the examination. PES has worked with credentialing organizations for more than 50 years and counts among its clients such organizations as Association of State and Provincial Psychology Boards (ASPPB), American Association of Critical Care Nurses, Association of Marital and Family Therapy Regulatory Boards, and American Board of Clinical Neuropsychology.

To develop valid test specifications based on the above-described content-and-knowledge-based delineation, PES worked with an expert panel of 17, comprised of psychologists, physicians, an advanced practice nurse, and a pharmacologist. All of the experts were selected for their particular expertise in psychopharmacology. The psychologists carried additional training, i.e., medical degree, doctoral degree in pharmacology and postdoctoral fellowships in clinical or research psychopharmacology. Seven of the ten graduates of the DoD Psychopharmacology Demonstration Project participated. Over 100 additional subject-matter experts provided review and comment. A representative from ASPPB, which develops the examination used to license psychologists (EPPP), participated throughout the project. Concurrent with the content-and-knowledge-based delineation, a process-based delineation was also developed. This delineation can be considered a valid statement of the tasks underlying the practice of psychology in both clinical and research settings when psychotropic medications are involved. PES conducted a large-scale survey involving approximately 600 psychologists, as well as a small number of psychiatrists, to validate the content areas, knowledge statements, and tasks.

Finally, PES worked with members of the expert panel and additional subject-matter experts to develop examination items, construct two forms of the examination, and set a recommended passing score. The exam will be administered via computer at specially designated computer-based testing (CBT) centers.

Commitment to Maintaining the Quality and Defensibility of the Examination

The College is committed to a long-term responsibility for maintaining the examination’s quality and defensibility for use by licensing entities. This means that item performance will be monitored by PES on a continuing basis; experts will meet periodically to review item performance statistics, edit items, write new items, update the exam forms, develop additional exam forms, if needed, as well as monitor and revise the content-and-process-based delineation as the field changes and knowledge increases.


Janet Ciuccio is Executive Administrator of the College of Professional Psychology. For further information, contact her or the College at 202-336-6100 or E-mail apacollege@apa.org. Her direct phone number is 202-336-5879.

Return to Top